electroCore, Inc.
NASDAQ:ECOR
EV/OCF
Enterprise Value to OCF
Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.
Market Cap | EV/OCF | ||||
---|---|---|---|---|---|
US |
electroCore, Inc.
NASDAQ:ECOR
|
40.9m USD | -2.9 | ||
US |
Abbott Laboratories
NYSE:ABT
|
179.1B USD | 25.9 | ||
US |
Intuitive Surgical Inc
NASDAQ:ISRG
|
142B USD | 80.2 | ||
US |
Stryker Corp
NYSE:SYK
|
125.7B USD | 38.7 | ||
IE |
Medtronic PLC
NYSE:MDT
|
113.2B USD | 20.1 | ||
US |
Boston Scientific Corp
NYSE:BSX
|
111.5B USD | 47.9 | ||
US |
Becton Dickinson and Co
NYSE:BDX
|
68.2B USD | 21.5 | ||
DE |
Siemens Healthineers AG
XETRA:SHL
|
59.8B EUR | 36.8 | ||
US |
Edwards Lifesciences Corp
NYSE:EW
|
54.2B USD | 59.3 | ||
US |
Dexcom Inc
NASDAQ:DXCM
|
51.9B USD | 64.1 | ||
CN |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
369.4B CNY | 27.9 |
EV/OCF Forward Multiples
Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.